Application 060359

Type: ANDA
Sponsor: ARBOR PHARMS LLC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	TABLET;ORAL	EQ 250MG BASE	No	Yes
002	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	TABLET;ORAL	EQ 125MG BASE	No	No
003	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	TABLET;ORAL	EQ 500MG BASE	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS
A060359-001	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982
A060359-002	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982
A060359-003	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A060359-002	ERYTHROCIN STEARATE	EQ 125MG BASE	TABLET / ORAL	Approved before 1982	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A060359-003	ERYTHROCIN STEARATE	EQ 500MG BASE	TABLET / ORAL	Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A060359-001	ERYTHROCIN STEARATE	EQ 250MG BASE	TABLET / ORAL	RS, Approved before 1982	`8072bd15b7f6…`

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
10544-594	Erythrocin Stearate	Erythromycin Stearate	Blenheim Pharmacal, Inc.	ANDA	Current
10544-595	Erythrocin Stearate	Erythromycin Stearate	Blenheim Pharmacal, Inc.	ANDA	Current
24338-106	Erythrocin Stearate	ERYTHROMYCIN STEARATE	Arbor Pharmaceuticals, Inc.	ANDA	Current
50090-0025	Erythrocin Stearate	ERYTHROMYCIN STEARATE	A-S Medication Solutions	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
18302	SUPPL	2014-01-31